4//SEC Filing
Lambert Nicole 4
Accession 0001209191-23-038150
CIK 0001724521other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 8:11 PM ET
Size
7.2 KB
Accession
0001209191-23-038150
Insider Transaction Report
Form 4
Lambert Nicole
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-15+19,500→ 19,500 totalExercise: $19.60Exp: 2033-06-14→ Common Stock (19,500 underlying) - Award
Common Stock
2023-06-15+6,800→ 15,600 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control.
- [F2]The option will vest in full on the earlier of June 15, 2024 or the next annual meeting of stockholders of the issuer. The option becomes fully vested and exercisable in the event the Company is subject to a change in control.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001770252
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 8:11 PM ET
- Size
- 7.2 KB